AlertEdge.io
Single-Ticker Trade Brief
MDLZ — Mondelez International Report Date: 2026-08-19 20:39 UTC  |  Sector: Consumer Staples  |  Rating:
RISK DISCLAIMER: This is an automated breakout signal. Always validate before entering a position.
▲ Breakout Signal — Volume Confirmed

MDLZ closed above the $64.09 breakout level on 1.57x average volume. ATR-based levels set automatically. Next resistance target: $65.99.

Ticker
MDLZ
Entry Price
$64.17
Breakout Level
$64.09
Stop Loss
$63.18
TP1 Target
$65.99
TP2 Target
$67.21
Risk / Reward
1 : 1.84
1.57x avg volume
View MDLZ Chart on TradingView

Key Price Levels

TP1 Target
$65.99
Breakout Level
$64.09
Entry
$64.17
Stop Loss
$63.18

Fundamentals

P/E Ratio
N/A
EPS (TTM)
N/A
Dividend Yield
0%
52-Wk High
N/A
52-Wk Low
N/A
Beta
N/A

Deep Dive Analysis — Claude Sonnet

MDLZ — Mondelez International | Consumer Staples | Breakout Brief

SETUP

Price cleared the $64.09 breakout level with conviction, closing near session highs at $64.17 after opening at $63.78. The candle shows a clean hold above the trigger with no wick rejection at the breakout zone, suggesting buyers absorbed supply. Volume came in at 1.57x average, confirming institutional participation rather than a low-conviction drift higher. The risk/reward of 1:1.84 is acceptable, with a tight $0.99 stop below and $3.04 of upside to TP2.

CATALYSTS

Q2 sales beat expectations and management raised its 2026 growth outlook, giving the stock a fundamental catalyst to support the technical move. Consumer Staples are attracting defensive rotation in volatile macro conditions, and MDLZ fits that profile as a large-cap, globally diversified snack giant. Organic growth momentum into 2026 is a credible near-term tailwind if execution holds.

RISKS

The signal quality score of 50/100 is the primary concern here — this is not an early-in-move setup, meaning the easy money may already be off the table. Fundamentals data is largely missing (no P/E, no 52-week range, no beta), which limits confidence in valuation context. The "rich valuation" narrative appearing in analyst coverage is a headwind if macro conditions soften or rates stay elevated. GLP-1 drug adoption remains a structural overhang for snack food demand — this is a slow-burn risk but a real one. A close back below $63.78 would negate the breakout and signal a failed attempt.

CONVICTION: Medium — The breakout is technically valid with above-average volume, but the middling signal quality score and missing fundamental data prevent higher conviction, and valuation concerns cap the upside case.